169 related articles for article (PubMed ID: 25471788)
1. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
[TBL] [Abstract][Full Text] [Related]
2. Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2.
Kuczynski EA; Viloria-Petit AM; Coomber BL
Cancer; 2011 Dec; 117(24):5601-11. PubMed ID: 21692070
[TBL] [Abstract][Full Text] [Related]
3. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
4. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
5. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis.
Song X; An Y; Chen D; Zhang W; Wu X; Li C; Wang S; Dong W; Wang B; Liu T; Zhong W; Sun T; Cao H
Cancer Sci; 2022 Feb; 113(2):459-477. PubMed ID: 34811848
[TBL] [Abstract][Full Text] [Related]
6. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
Zheng X; Wei J; Li W; Li X; Wang W; Guo J; Fu Z
Aging (Albany NY); 2020 Jul; 12(16):16390-16409. PubMed ID: 32692719
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
[TBL] [Abstract][Full Text] [Related]
8. Blocking effects of siRNA on VEGF expression in human colorectal cancer cells.
Yin Y; Cao LY; Wu WQ; Li H; Jiang Y; Zhang HF
World J Gastroenterol; 2010 Mar; 16(9):1086-92. PubMed ID: 20205278
[TBL] [Abstract][Full Text] [Related]
9. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L
Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048
[TBL] [Abstract][Full Text] [Related]
11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
12. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
[TBL] [Abstract][Full Text] [Related]
14. Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.
Duan S
Cancer Biomark; 2018 Feb; 21(3):565-574. PubMed ID: 29278874
[TBL] [Abstract][Full Text] [Related]
15. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts.
Chen S; Liu X; Gong W; Yang H; Luo D; Zuo X; Li W; Wu P; Liu L; Xu Q; Ji A
Oncol Rep; 2013 Jan; 29(1):260-8. PubMed ID: 23117577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
